Changes
On April 25, 2022 at 6:41:02 PM UTC,
-
Removed author from Malawi Integrated Clinical HIV Guidelines 2nd Edition 2014
-
Removed author email from Malawi Integrated Clinical HIV Guidelines 2nd Edition 2014
-
Updated description of Malawi Integrated Clinical HIV Guidelines 2nd Edition 2014 to
In July 2013, the WHO released new __Consolidated Guidelines for the use of Antiretroviral Drugs for Treating and Prevention of HIV Infection__. The 2013 WHO guidelines advocate for the use of ARVs within a broad continuum of care and include guidance for implementation and M&E. This strategy of harmonization, integration and simplification follows the same principles that were introduced in the 1st Edition of the Malawi Guidelines in 2011.
-
Changed the license of Malawi Integrated Clinical HIV Guidelines 2nd Edition 2014 to License not specified (previously None)
f | 1 | { | f | 1 | { |
n | n | 2 | "author": "", | ||
3 | "author_email": "", | ||||
2 | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | 4 | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | ||
3 | "groups": [ | 5 | "groups": [ | ||
4 | { | 6 | { | ||
5 | "description": "Group for guidelines", | 7 | "description": "Group for guidelines", | ||
6 | "display_name": "Guideline", | 8 | "display_name": "Guideline", | ||
7 | "id": "88e0ef3f-7d7e-44a5-9234-084f8c170d82", | 9 | "id": "88e0ef3f-7d7e-44a5-9234-084f8c170d82", | ||
8 | "image_display_url": | 10 | "image_display_url": | ||
9 | 3-17-123643.7336343533402businessmanagementplanprojectreporticon.png", | 11 | 3-17-123643.7336343533402businessmanagementplanprojectreporticon.png", | ||
10 | "name": "guideline", | 12 | "name": "guideline", | ||
11 | "title": "Guideline" | 13 | "title": "Guideline" | ||
12 | } | 14 | } | ||
13 | ], | 15 | ], | ||
14 | "id": "f8180061-c680-41fd-8b8a-a0d84cd84ab1", | 16 | "id": "f8180061-c680-41fd-8b8a-a0d84cd84ab1", | ||
15 | "isopen": false, | 17 | "isopen": false, | ||
n | 16 | "license_title": null, | n | 18 | "license_id": "notspecified", |
19 | "license_title": "License not specified", | ||||
17 | "maintainer": null, | 20 | "maintainer": null, | ||
18 | "maintainer_email": null, | 21 | "maintainer_email": null, | ||
19 | "metadata_created": "2021-09-16T08:11:58.671128", | 22 | "metadata_created": "2021-09-16T08:11:58.671128", | ||
n | 20 | "metadata_modified": "2022-04-04T09:26:47.530637", | n | 23 | "metadata_modified": "2022-04-25T18:41:02.339155", |
21 | "name": | 24 | "name": | ||
22 | "malawi-integrated-clinical-hiv-guidelines-2nd-edition-2014", | 25 | "malawi-integrated-clinical-hiv-guidelines-2nd-edition-2014", | ||
n | n | 26 | "notes": "In July 2013, the WHO released new __Consolidated | ||
27 | Guidelines for the use of Antiretroviral Drugs for Treating and | ||||
28 | Prevention of HIV Infection__. The 2013 WHO guidelines advocate for | ||||
29 | the use of ARVs within a broad continuum of care and include guidance | ||||
30 | for implementation and M&E. This strategy of harmonization, | ||||
31 | integration and simplification follows the same principles that were | ||||
32 | introduced in the 1st Edition of the Malawi Guidelines in 2011.", | ||||
23 | "num_resources": 1, | 33 | "num_resources": 1, | ||
24 | "num_tags": 0, | 34 | "num_tags": 0, | ||
25 | "organization": { | 35 | "organization": { | ||
26 | "approval_status": "approved", | 36 | "approval_status": "approved", | ||
27 | "created": "2021-10-14T11:02:35.234558", | 37 | "created": "2021-10-14T11:02:35.234558", | ||
n | 28 | "description": "Department of HIV & AIDS and Viral Hepatitis", | n | 38 | "description": "The Department of HIV & AIDS (DHA) was established |
39 | in 2001, initially as a unit in the Department of Clinical Services, | ||||
40 | to coordinate the biomedical HIV Program in Malawi. The department now | ||||
41 | carries responsibility for various HIV related programs including: | ||||
42 | sexually transmitted infections (STIs), prevention of mother to child | ||||
43 | transmission of HIV (PMTCT), and national voluntary male medical | ||||
44 | circumcision program (VMMC). All these HIV program sub-sections are | ||||
45 | linked to one robust monitoring and evaluation sub-section in the HIV | ||||
46 | and AIDS Department which technically operates under the Central | ||||
47 | Monitoring and Evaluation Department (CMED) of the Ministry of | ||||
48 | Health.", | ||||
29 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 49 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
n | 30 | "image_url": "", | n | 50 | "image_url": |
51 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | ||||
31 | "is_organization": true, | 52 | "is_organization": true, | ||
32 | "name": "dha", | 53 | "name": "dha", | ||
33 | "state": "active", | 54 | "state": "active", | ||
t | 34 | "title": "Department of HIV & AIDS", | t | 55 | "title": "Department of HIV & AIDS and Viral Hepatitis", |
35 | "type": "organization" | 56 | "type": "organization" | ||
36 | }, | 57 | }, | ||
37 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 58 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
38 | "private": false, | 59 | "private": false, | ||
39 | "program_area": "Care and Treatment", | 60 | "program_area": "Care and Treatment", | ||
40 | "relationships_as_object": [], | 61 | "relationships_as_object": [], | ||
41 | "relationships_as_subject": [], | 62 | "relationships_as_subject": [], | ||
42 | "resources": [ | 63 | "resources": [ | ||
43 | { | 64 | { | ||
44 | "cache_last_updated": null, | 65 | "cache_last_updated": null, | ||
45 | "cache_url": null, | 66 | "cache_url": null, | ||
46 | "created": "2022-03-23T19:56:07.721818", | 67 | "created": "2022-03-23T19:56:07.721818", | ||
47 | "description": "", | 68 | "description": "", | ||
48 | "format": "PDF", | 69 | "format": "PDF", | ||
49 | "hash": "", | 70 | "hash": "", | ||
50 | "id": "f87c97e0-1f3e-409b-a89d-600e1be7c825", | 71 | "id": "f87c97e0-1f3e-409b-a89d-600e1be7c825", | ||
51 | "last_modified": "2022-04-04T09:26:47.522634", | 72 | "last_modified": "2022-04-04T09:26:47.522634", | ||
52 | "lfs_prefix": | 73 | "lfs_prefix": | ||
53 | "dha/malawi-integrated-clinical-hiv-guidelines-2nd-edition-2014", | 74 | "dha/malawi-integrated-clinical-hiv-guidelines-2nd-edition-2014", | ||
54 | "metadata_modified": "2022-04-04T09:26:47.545657", | 75 | "metadata_modified": "2022-04-04T09:26:47.545657", | ||
55 | "mimetype": "application/pdf", | 76 | "mimetype": "application/pdf", | ||
56 | "mimetype_inner": null, | 77 | "mimetype_inner": null, | ||
57 | "name": | 78 | "name": | ||
58 | "malawi-integrated-clinical-hiv-guidelines-2nd-edition-2014", | 79 | "malawi-integrated-clinical-hiv-guidelines-2nd-edition-2014", | ||
59 | "package_id": "f8180061-c680-41fd-8b8a-a0d84cd84ab1", | 80 | "package_id": "f8180061-c680-41fd-8b8a-a0d84cd84ab1", | ||
60 | "position": 0, | 81 | "position": 0, | ||
61 | "resource_type": null, | 82 | "resource_type": null, | ||
62 | "sha256": | 83 | "sha256": | ||
63 | "ec1e6eae1054801b96286274a1d8838471807579710cfaa01609b75763be4696", | 84 | "ec1e6eae1054801b96286274a1d8838471807579710cfaa01609b75763be4696", | ||
64 | "size": 1828364, | 85 | "size": 1828364, | ||
65 | "state": "active", | 86 | "state": "active", | ||
66 | "url": | 87 | "url": | ||
67 | nload/malawi-integrated-clinical-hiv-guidelines-2nd-edition-2014.pdf", | 88 | nload/malawi-integrated-clinical-hiv-guidelines-2nd-edition-2014.pdf", | ||
68 | "url_type": "upload" | 89 | "url_type": "upload" | ||
69 | } | 90 | } | ||
70 | ], | 91 | ], | ||
71 | "state": "active", | 92 | "state": "active", | ||
72 | "tags": [], | 93 | "tags": [], | ||
73 | "title": "Malawi Integrated Clinical HIV Guidelines 2nd Edition | 94 | "title": "Malawi Integrated Clinical HIV Guidelines 2nd Edition | ||
74 | 2014", | 95 | 2014", | ||
75 | "type": "dataset", | 96 | "type": "dataset", | ||
76 | "url": null, | 97 | "url": null, | ||
77 | "version": null, | 98 | "version": null, | ||
78 | "year": "2014" | 99 | "year": "2014" | ||
79 | } | 100 | } |